Erratum: Buying the Unlimited Turbo Put for Novo Nordisk at €0.64
Analysis: Novo Nordisk is one of the cheapest stocks in Europe and the cheapest in the pharma sector. For almost two months it has been trying to rise again. It got close to a big down‑trend gap that opened after its earnings, when the company cut its 2026 profit outlook. This gap now acts as a ceiling and may push sellers back in. We expect the price could fall to support levels around 286.9 and 266.4 DKK.
If the price breaks the strong resistance at 321.95 DKK, the downtrend could be cancelled.
Product Choice: Vontobel Turbo Infinite Put
The Vontobel Turbo Infinite Put on Novo Nordisk (ISIN DE000VY2YL48) fits this technical picture. It has no expiry date, a de‑activation barrier at 320.68 DKK and a strike price of 333.66 DKK. Its current leverage is about 6. You can buy it for €0.64, aiming for the stock to reach 266.4 DKK, with the trade becoming invalid if the price reaches 321.95 DKK.
We will keep an eye on this trade and update you when we think it is time to sell. The trade stops working if the product is de‑activated. All targets and barriers are for information only and may change with market conditions.
Legal warning: Future performance numbers are only forecasts and are not reliable indicators of actual future results.
Key Levels
| Support 1 | 286.9 |
|---|---|
| Support 2 | 266.4 |
| Resistance 1 | 321.95 |
| Resistance 2 | 357.5 |
| Target | 266.4 |
| Invalidation | 320.95 |
| Short‑term Opinion | Negative |
| Long‑term Opinion | Downward |
